# Phase 13 Docs / Runbook Alignment V1

Status: Complete
Created: 2026-05-30

## Summary

Alignment result: `QA_PASS`

The durable docs now point to the same 1차 hardening cycle interpretation:

- Phase 8~12 improved investability evidence from lifecycle / survivorship through selected monitoring.
- Final Decision V2 is the current selected dashboard source.
- DB-backed raw/full evidence and workflow JSONL compact evidence remain separate.
- saved setup, reports, run history, run artifacts, and Playwright output do not replace DB / registry source-of-truth.
- selected monitoring surfaces do not imply live approval, broker order, or auto rebalance.

## Alignment Matrix

| Document | Update | Why |
| --- | --- | --- |
| `docs/data/STORAGE_GOVERNANCE.md` | Added Phase 13 alignment notes and runtime-defined JSONL path clarification | Prevent V2 files absent on disk from being mistaken for drift; keep DB / JSONL boundary explicit |
| `docs/data/README.md` | Updated Last Verified and JSONL boundary wording | Make the data map match current storage audit language |
| `docs/flows/README.md` | Updated Last Verified and selected dashboard boundary language | Keep top-level flow aligned with read-only monitoring and no trading automation |
| `docs/flows/PORTFOLIO_SELECTION_FLOW.md` | Updated Last Verified and storage boundary note | Keep the canonical Portfolio Selection V2 chain explicit |
| `docs/flows/BACKTEST_UI_FLOW.md` | Added Last Verified and corrected stale Final Decision V1 references to V2 where current flow is described | Prevent future readers from using legacy V1 as selected dashboard source |
| `docs/GLOSSARY.md` | Updated Last Verified and Final Review decision storage wording | Keep glossary definitions aligned with current Final Decision V2 registry |
| `docs/runbooks/PHASE_CLOSEOUT_QA.md` | Added repeatable phase closeout QA procedure | Make Phase 13 final QA steps reusable for future phases |
| `docs/runbooks/README.md` | Linked the new runbook and refreshed focused check guidance | Improve discoverability |
| `docs/INDEX.md`, `docs/ROADMAP.md` | Moved current focus to 13-5 | Keep navigation aligned |

## Out Of Scope Confirmed

- No code changes.
- No registry / saved JSONL changes.
- No run history / run artifact / Playwright output changes.
- No user memo / preset / monitoring log auto-write.
- No broker order, live approval, account sync, or auto rebalance.

## Follow-Up

Next task: `phase13-residual-risk-carry-forward-v1`

13-5 should triage remaining gaps into:

- current product limitations;
- second-cycle candidates;
- out-of-scope broker-grade / production operations items.
